Robin K. Avery

17.8k citations
230 papers · 10.8k · 5 hit papers · h-index 54

Impact in

Papers in

    • Cytomegalovirus and herpesvirus research 69
    • Herpesvirus Infections and Treatments 18
    • COVID-19 Clinical Research Studies 22
    • Antifungal resistance and susceptibility 22
    • SARS-CoV-2 and COVID-19 Research 21

Robin K. Avery

222 papers receiving 10.6k citations

Robin K. Avery's Hit Papers

Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial 2021 · 180 citations
1800+4+8Years since publication2505007501000

Peers

Robin K. Avery
Comparison fields: 5 of 127
  • Transplantation 905
  • Infectious Diseases 3.9k
  • Epidemiology 5.1k
  • Microbiology 62
  • Hepatology 505
Replace José María Aguado with:
José María Aguado Spain
Lindsey R. Baden United States
Raymund R. Razonable United States
Atul Humar Canada
Per Ljungman Sweden
Asunción Moreno Spain
Emily A. Blumberg United States
Ajit P. Limaye United States
Michael G. Ison United States
Marian G. Michaels United States
Robin K. Avery relative to José María Aguado Spain José María Aguado's profile →
Citations per field
00.5×1.5×2.2×
José María Aguado · 1×
Citations per year

Countries citing papers authored by Robin K. Avery

Since Specialization
Citations

This map shows the geographic impact of Robin K. Avery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin K. Avery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin K. Avery more than expected).

Fields of papers citing papers by Robin K. Avery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin K. Avery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin K. Avery. The network helps show where Robin K. Avery may publish in the future.

Co-authors

The 25 scholars most cited alongside Robin K. Avery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robin K. Avery Line = papers co-authored together Robin K. Avery links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 230 papers — load more, or switch the sort, to bring in the rest.

#Work
1
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Hit paper breakdown →
20131096
2
Executive Summary: 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Hit paper breakdown →
2014664
3
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
Hit paper breakdown →
2021598
4
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients
Hit paper breakdown →
2021343
5 2002287
6 2003247
7 2009212
8 2020191
9
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial
Hit paper breakdown →
2021180
10 2010178
11 2003170
12 2018167
13 2018166
14 2011163
15 1998149
16 2009142
17 1999138
18 2016124
19 2011124
20 2001121

About Robin K. Avery

Robin K. Avery is a scholar working on Epidemiology, Infectious Diseases, Oncology, Surgery and Transplantation, having authored 230 papers that have together received 10.8k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (69 papers), Transplantation: Methods and Outcomes (25 papers), Polyomavirus and related diseases (22 papers), COVID-19 Clinical Research Studies (22 papers), Antifungal resistance and susceptibility (22 papers), SARS-CoV-2 and COVID-19 Research (21 papers), Herpesvirus Infections and Treatments (18 papers) and Renal Transplantation Outcomes and Treatments (17 papers). The work is most often cited by research in Transplantation (905 citations), Infectious Diseases (3.9k citations), Epidemiology (5.1k citations), Microbiology (62 citations) and Hepatology (505 citations). Robin K. Avery has collaborated with scholars based in United States, Canada and Thailand. Frequent co-authors include Allan B. Massie, Per Ljungman, William A. Werbel, Jacqueline Garonzik‐Wang, Dorry L. Segev, Brian J. Boyarsky, Lillian Sung, Myron J. Levin, Marcie Tomblyn and Shireesha Dhanireddy. Their work appears in journals such as American Journal of Transplantation, Transplantation, Clinical Infectious Diseases, The Journal of Heart and Lung Transplantation and Open Forum Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact